|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00911 QIANHAI HEALTH
Nominal 
0.335 0.000 (0.000%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 306,970 | -9.688% | 961,291 | 1,961,704 | 283,398 | 760,721 |
| Cost of Sales | (264,074) | -23.748% | (996,894) | (1,885,222) | (267,360) | (715,593) |
| Gross Profit | 42,896 | -- | (35,603) | 76,482 | 16,038 | 45,128 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | (1,639) | |
| Profit / (Loss) before Taxation | 15,548 | -- | (52,705) | (233,703) | (888) | (804) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 15,548 | -- | (52,705) | (233,703) | (888) | (804) | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (94) | 327.273% | (26) | (66) | 389 | 1,633 |
| Depreciation & Amortisation | 1,216 | 0.000% | 2,433 | 2,434 | 2,436 | 3,024 |
| Directors' Emoluments | -- | -- | 1,335 | 2,649 | 4,268 | 5,471 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Qualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 9.180 | -- | -31.100 | -137.900 | -0.500 | -0.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.005 | (0.031) | (0.026) | (0.042) |
| NBV per share ($) | 2.360 | -- | 2.267 | 2.577 | 3.957231 | 3.976854 |
| Remarks: | Real time quote last updated: 11/11/2024 08:13 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 15,548,000 |
| %Change | -- |
| EPS / (LPS) | HKD 0.092 |
| NBV Per Share ($) | HKD 2.360 |